At steady state, the difference between injecting on day six versus day seven is smaller in absolute terms than during the initial titration phase
The medications currently approved by the FDA for this purpose are Foundayo (orforglipron), Zepbound (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide)
To view or add a comment, sign in More Relevant Posts On 5 June 2025, the US Food and Drug Administration (FDA) approved WIDAPLIK (telmisartan, amlodipine and indapamide) tablets, for oral use, for the treatment of hypertension in adult patients, including as initial treatment, to lower blood pressure
If you have a diagnosed health condition including Type 2 diabetes, cardiovascular disease, or any condition affecting your metabolism please discuss any lifestyle changes with your doctor before making them
These advanced medications are FDA-approved for obesity, helping patients achieve and sustain meaningful change when lifestyle changes alone fall short
Zepbound and Wegovy are taken once a week, while Saxenda is taken daily